Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  BioSig Technologies, Inc.    BSGM

BIOSIG TECHNOLOGIES, INC.

(BSGM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

BIOSIG TECHNOLOGIES, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

02/23/2021 | 01:33pm EST
Item 7.01           Regulation FD Disclosure.



BioSig Technologies, Inc. (the "Company") intends, from time to time, to present, utilize, and/or distribute to the investment community and utilize at various industry and other conferences, a slide presentation, which is attached hereto as Exhibit 99.1. The Company undertakes no obligation to update, supplement or amend the materials attached hereto as Exhibit 99.1.

In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by reference in such a filing. Furthermore, the furnishing of information under Item 7.01 of this Current Report on Form 8-K is not intended to constitute a determination by the Company that the information contained herein, including the exhibits hereto, is material or that the dissemination of such information is required by Regulation FD.



Item 9.01       Financial Statements and Exhibits.



(d) Exhibits



Exhibit Number   Description
99.1               Corporate Presentation, Winter 2021 (furnished herewith pursuant to
                 Item 7.01)
104              Cover Page Interactive Data File (formatted as Inline XBRL)








--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about BIOSIG TECHNOLOGIES, INC.
03/04BIOSIG TECHNOLOGIES  : Awarded US Patent for Method of Treating High Blood Press..
MT
03/04BioSig Awarded U.S. Patent Claims for its NeuroClear™ Subsidiary
GL
02/25BIOSIG TECHNOLOGIES, INC.  : Regulation FD Disclosure, Financial Statements and ..
AQ
02/23BIOSIG TECHNOLOGIES, INC.  : Regulation FD Disclosure, Financial Statements and ..
AQ
02/18BIOSIG TECHNOLOGIES  : Looking After Your Heart Health During COVID-19
PU
02/18BIOSIG TECHNOLOGIES  : February may be the shortest month of the year, but it af..
PU
02/16BioSig Appoints Brenda Castrodad to Lead Human Resources
GL
02/11BIOSIG TECHNOLOGIES, INC.  : Regulation FD Disclosure, Financial Statements and ..
AQ
02/10Major Medical Centers Enter into Installation Agreements for Evaluation of Bi..
GL
02/09INSIDER TRENDS : BioSig Technologies Insider Disposition Interrupting 90-Day Buy..
MT
More news